Observation and Consideration on Using of JAKi in Clinical Trials in Times of COVID-19

    June 2020 in “ Dermatologic therapy ”
    Jinqiang Yang, Maher Al‐Muriesh, Yan Li, Xiangjie An, Juan Tao
    TLDR Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.
    The document discussed the use of JAK inhibitors (JAKi) like tofacitinib for treating alopecia areata (AA) during the COVID-19 pandemic. It highlighted concerns about increased infection risks due to JAKi, given their role in the JAK/STAT pathway, which is involved in severe COVID-19 cases. The study reported on three AA patients in Hubei, China, who took JAKi during the pandemic and did not contract COVID-19. Two patients showed hair growth, while one did not. The authors concluded that JAKi did not increase COVID-19 infection risk in these cases but emphasized the need for more data to confirm the safety and efficacy of JAKi during the pandemic. They also provided recommendations for safely continuing clinical trials during such times.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 69 results
      Compressed part of research of theory of androgenic/anabolitic balance. AGA h-responders analytic. Theory of physio-metabolitic method of anti AGA treatment

      community Compressed part of research of theory of androgenic/anabolitic balance. AGA h-responders analytic. Theory of physio-metabolitic method of anti AGA treatment

      by MagicBold in Research  865 upvotes 1 year ago
      The treatment for androgenetic alopecia involves using finasteride and minoxidil with intense exercise and cold exposure to boost metabolism and reduce androgenic effects, potentially leading to hair regrowth. This approach may activate biological pathways for improved hair and overall health.

      community What else is good. Besides the big 3.

      in Chat  35 upvotes 1 year ago
      Key treatments for hair preservation include minoxidil, finasteride/dutasteride, and microneedling, with additional options like specific shampoos, oils, biotin, zinc, tretinoin, clascoterone, and low-level laser therapy. Maintaining a healthy lifestyle, reducing stress, and addressing nutrient deficiencies can also support hair health.

      community 22F. Should I even bother getting a biopsy? Is there any point?

       7 upvotes 9 years ago
      A woman who has been experiencing hair loss for several years, and her question of whether there is any benefit to getting a biopsy to check if it's AGA or diffuse alopecia areata when no cure or very effective treatment exists. Treatments such as spironolactone and Minoxidil/finasteride/RU58841 have previously been discussed.

      community can someone help me identify these pls

      in Treatment 4 months ago
      The user is experiencing diffuse thinning and inflammation despite using 2.5mg dutasteride daily, ciclopirox, and ketoconazole shampoos. They are considering treatments like hydroxychloroquine and JAK inhibitors due to suspected scarring alopecia and have faced challenges in obtaining a scalp biopsy.

      community Xeljanz....the magic drug!!!

       2 upvotes 7 years ago
      A user experienced significant hair regrowth from Xeljanz after severe alopecia but can no longer afford it. They are seeking ways to obtain the medication despite its high cost and potential side effects.

      community DUPA, Non Responders and Connective Tissue Disorders

      in Research/Science  9 upvotes 9 months ago
      A 27-year-old male with diffuse hair loss, including the donor area, did not respond to finasteride, dutasteride, or minoxidil. He suspects his hair loss may be linked to a mild connective tissue disorder, possibly affecting the structural support of hair follicles, rather than being purely hormonal.

    Similar Research

    6 / 1000+ results